Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • karl_s
    Junior Member
    • Dec 2013
    • 9

    #1

    varScan output question

    Hi Folks,
    this might seem like a naive quesiton, but please bear with me. Here is the output of two different varscan runs on a patient sample pre and post treatment.Each one is generated with seperate calls to mpileuptosnp, and are in different, single sample mpileup files. I am wondering why the consensus output (which is an amino acid code) is different for these samples when the variant allele is the same? In frame, both GAG and GAA should generate an E, not an R.

    Chrom Position Ref Var Cons:Cov:Reads1:Reads2:Freq:P-value StrandFilter:R1+:R1-:R2+:R2-val SamplesRef SamplesHet SamplesHom SamplesNC Cons:Cov:Reads1:Reads2:Freq:P-value
    200-013-3_20_13_L7.LB2.snp:chr17 1631724 G A A:26:3:23:88.46%:7.3681E-12 Pass:3:0:12:11:1E0 0 0 1 0 A:26:3:23:88.46%:7.3681E-12
    200-306-D1_L7.LB1.snp:chr17 1631724 G A R:24:11:13:54.17%:1.2938E-5 Pass:6:5:5:8:1E0 0 1 0 0 R:24:11:13:54.17%:1.2938E-5


    Maybe I am not understanding the varscan mpileup2snp output completely.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
41 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...